Boston Baskin Cancer Group, University Tennessee Oncology/Hematology Group — Memphis, Tennessee

Boston Baskin Cancer Group, University Tennessee Oncology/Hematology Group is a clinical research site located in Memphis, Tennessee, United States 38119.

Crixeo Clinical Trials Trust Score: 80/100 (GOOD). This profile has not yet been claimed by the site owner.

Boston Baskin Cancer Group, University Tennessee Oncology/Hematology Group has participated in 5 clinical trials.

Therapeutic areas: Metastatic Cancer, Lung Cancer, Leukemia.

Sponsors: Spectrum Pharmaceuticals, Inc, Amgen, Pharmatech Oncology.

Is this your site?

Is this your site? Claim your profile and control the information sponsors and patients see.

Other research sites in Memphis

Browse all research sites in Tennessee · View every site in Memphis

• UTHSC Lebonheur Children's Hospital
• Baptist Memorial Hospital Cancer Center
• Methodist Healthcare - Memphis Hospitals
• University of TN Health Sciences Centre
• Ohio State University-Telemedicine
• Methodist University Hospital/University of Tennessee Health Science Center, Office of Clinical Research
• Memphis Veterans Affairs Medical Center
• Baptist Memphis Hospital
• Baptist Memorial Hospital and Cancer Center-Memphis
• Methodist Hospitals of Memphis
• University of Tennessee CF Care and Research Center
• University of Tennessee Health Science Center; Le Bonheur Children's Hospital

Sponsor Feasibility Report

Trust Score: 80/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Boston Baskin Cancer Group, University Tennessee Oncology/Hematology Group?

Boston Baskin Cancer Group, University Tennessee Oncology/Hematology Group has a Crixeo Trust Score of 80/100 (GOOD). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Boston Baskin Cancer Group, University Tennessee Oncology/Hematology Group conducted?

Boston Baskin Cancer Group, University Tennessee Oncology/Hematology Group has 5 clinical trials on record. Their work covers Metastatic Cancer, Lung Cancer, Leukemia.

Is Boston Baskin Cancer Group, University Tennessee Oncology/Hematology Group accredited by Crixeo Clinical Trials?

Boston Baskin Cancer Group, University Tennessee Oncology/Hematology Group has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about Boston Baskin Cancer Group, University Tennessee Oncology/Hematology Group?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.